Literature DB >> 30419265

Ancistrobrevines E-J and related naphthylisoquinoline alkaloids from the West African liana Ancistrocladus abbreviatus with inhibitory activities against Plasmodium falciparum and PANC-1 human pancreatic cancer cells.

Shaimaa Fayez1, Doris Feineis1, Laurent Aké Assi2, Marcel Kaiser3, Reto Brun3, Suresh Awale4, Gerhard Bringmann5.   

Abstract

From the roots of the West African liana Ancistrocladus abbreviatus (Ancistrocladaceae), ten new naphthylisoquinoline alkaloids (7a, 7b, 8a, 8b, and 9-14), displaying three different coupling types (5,1', 5,8', and 7,8'), were isolated, among them a series of five 5,1'-linked representatives and four metabolites belonging to the rare group of 7,8'-coupled alkaloids. Two of the alkaloids, the ancistrobrevines I (13) and J (14), are only the fourth and fifth examples of 7,8'-linked naphthyldihydroisoquinolines ever found in nature. The stereostructures of the new plant metabolites were determined by spectroscopic, chemical (oxidative degradation), and chiroptical (electronic circular dichroism) methods. For the assignment of the axial configuration of 13 and 14 relative to the stereocenter at C-3, which is too far away for significant NOE long-range interactions, these 7,8'-coupled naphthyldihydroisoquinolines were stereoselectively converted into the respective cis-configured tetrahydroisoquinoline analogs. The newly generated 'auxiliary' stereocenter at C-1 permitted decisive NOE interactions between the isoquinoline and the naphthalene parts, and thus a reliable attribution of the axial configuration of 13 and 14. In addition, five known compounds (3, 5, 16, 17, and 20), previously discovered in related African and Asian Ancistrocladus species, have now for the first time been identified in A. abbreviatus. All of these alkaloids are S-configured at C-3 and bear an oxygen function at C-6, and are, thus, typical Ancistrocladaceae-type compounds. Some of the alkaloids of A. abbreviatus exhibited promising activities against the malaria parasite Plasmodium falciparum and PANC-1 human pancreatic cancer cells.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Ancistrobrevines; Ancistrocladus abbreviatus,Ancistrocladaceae; Anticancer agents; Antiplasmodial agents; Naphthylisoquinoline alkaloids

Mesh:

Substances:

Year:  2018        PMID: 30419265     DOI: 10.1016/j.fitote.2018.11.006

Source DB:  PubMed          Journal:  Fitoterapia        ISSN: 0367-326X            Impact factor:   2.882


  4 in total

1.  Ancistrobreveines A-D and related dehydrogenated naphthylisoquinoline alkaloids with antiproliferative activities against leukemia cells, from the West African liana Ancistrocladus abbreviatus.

Authors:  Shaimaa Fayez; Doris Feineis; Laurent Aké Assi; Ean-Jeong Seo; Thomas Efferth; Gerhard Bringmann
Journal:  RSC Adv       Date:  2019-05-20       Impact factor: 3.361

2.  The use of minimal topological differences to inspire the design of novel tetrahydroisoquinoline analogues with antimalarial activity.

Authors:  Joelleinsert Ngo Hanna; Vincent de Paul N Nziko; Fidele Ntie-Kang; James A Mbah; Flavien A A Toze
Journal:  Heliyon       Date:  2021-05-21

3.  Sidechain Diversification of Grandifloracin Allows Identification of Analogues with Enhanced Anti-Austerity Activity against Human PANC-1 Pancreatic Cancer Cells.

Authors:  Benjamin E Alexander; Sijia Sun; Matthew J Palframan; Gabriele Kociok-Köhn; Dya Fita Dibwe; Shiro Watanabe; Lorenzo Caggiano; Suresh Awale; Simon E Lewis
Journal:  ChemMedChem       Date:  2019-12-10       Impact factor: 3.466

4.  Spirofused tetrahydroisoquinoline-oxindole hybrids as a novel class of fast acting antimalarial agents with multiple modes of action.

Authors:  Noella M Efange; Maloba M M Lobe; Rodrigue Keumoe; Lawrence Ayong; Simon M N Efange
Journal:  Sci Rep       Date:  2020-10-21       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.